Summary
ACTIVE-W—one study under the larger umbrella of the ACTIVE (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) Trial—was discontinued in September 2005 after an excess risk of vascular events was observed in participants receiving clopidogrel plus aspirin compared with those receiving warfarin.
- arrhythmias
- clinical trials
- © 2005 MD Conference Express
Tools
ACTIVE-W Discontinued-Oral Anticoagulants Remain Treatment of Choice in Atrial Fibrillation
Permalink:
Table of contents
Cited By...
- No citing articles found.